MedPath

ADENOCARD LIQ IV 3MG/ML (PRE-FILLED SYRINGE)

ADENOCARD LIQ IV 3MG/ML (PRE-FILLED SYRINGE)

Discontinued
DIN Number

02031078

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

fujisawa pharmaceutical co, division of fujisawa canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02031078
AIG Number0113219001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C01EB10 ADENOSINE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification24:04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ADENOSINEActive
Strength: 3 MG / ML
Monograph: ADENOSINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.